CACTUS BIO LLC

Scottsdale, AZ · Medtech · Private

A point-of-care lateral flow test using recombinant CTS1 antigen to rapidly detect IgG/IgM antibodies against Coccidioides fungus for Valley Fever diagnosis in 10 minutes

Grants
$486K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · A Point-of-Care Test for Rapid Diagnosis of Valley Fever$243,118
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · A Point-of-Care Test for Rapid Diagnosis of Valley Fever$243,118
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1543QUA, INC.—$530K
1544Plasmonic Diagnostics LLC——
1545Breath Diagnostics, Inc.——
1546CACTUS BIO LLC——
1547HYPROTEK, INC.——
1548ClearCut Surgical, Inc.—$2.3M
1549NOTUS LABS, INC.—$105K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.